financetom
Business
financetom
/
Business
/
Greece hires banks for new 10-year bond sale
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Greece hires banks for new 10-year bond sale
Jan 13, 2025 4:05 AM

ATHENS, Jan 13 (Reuters) - Greece has hired six banks to

sell a new 10-year bond, its first issue this year, the

country's debt agency said on Monday.

The new bond will be launched "in the near future, subject

to market conditions," the debt agency said.

The country hired BofA Securities, Deutsche Bank, Goldman

Sachs Bank Europe SE, Morgan Stanley ( MS ), National Bank of Greece

and Societe Generale as joint lead managers.

Greece plans to raise up to 8 billion euros ($8.15

billion)from debt markets this year via medium- and long-term

bonds.

With a cash buffer of about 37 billion euros ($37.70

billion), enough to cover its debt needs for at least two years,

the sovereign will also repay ahead of schedule 5 billion euros

from its first bailout loans.

($1 = 0.9815 euros)

($1 = 0.9815 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With Greenwave Technology
What's Going On With Greenwave Technology
Jun 18, 2024
Greenwave Technology Solutions, Inc. ( GWAV ) shares are trading higher Tuesday after the company announced the completion of its recapitalization. The Details: Greenwave said it has strengthened its balance sheet by approximately $80.5 million since February and has a current cash balance of over $26 million, its strongest cash position in company history.  The company also said it is...
What's Going On With Mustang Bio Stock Tuesday?
What's Going On With Mustang Bio Stock Tuesday?
Jun 18, 2024
Mustang Bio, Inc. ( MBIO ) shares appear to be trending upward Tuesday on continued momentum after the company on Monday announced safety and efficacy data from its Phase 1/2 clinical trial of MB-106, a possible treatment for certain types of blood cancer. 90% of patients treated with MB-106 responded to the treatment with three complete responses. Out of the...
Lexaria Bioscience Hires Contract Research Organization For 12-week Study
Lexaria Bioscience Hires Contract Research Organization For 12-week Study
Jun 18, 2024
11:40 AM EDT, 06/18/2024 (MT Newswires) -- Lexaria Bioscience ( LEXX ) said Tuesday that it hired a contract research organization to manage its 12-week chronic study, GLP-1-H24-4, to evaluate different DehydraTECH-GLP-1 formulations and other treatments, focusing on goals such as weight loss and reducing blood sugar levels. Preparations for the study with the CRO have started under an initial...
Immunocore Randomizes First Patient in Phase 3 Trial of Cutaneous Melanoma Combination Treatment
Immunocore Randomizes First Patient in Phase 3 Trial of Cutaneous Melanoma Combination Treatment
Jun 18, 2024
11:40 AM EDT, 06/18/2024 (MT Newswires) -- Immunocore Holdings ( IMCR ) said Tuesday it has randomized the first patient in a phase 3 clinical trial of brenetafusp in combination with nivolumab to treat first-line advanced or metastatic cutaneous melanoma, a type of skin cancer. The trial will randomize patients with first-line advanced or metastatic cutaneous melanoma to brenetafusp plus...
Copyright 2023-2025 - www.financetom.com All Rights Reserved